Artificial Intelligence Analysis Of Advanced Breast Cancer Patients From A Phase I Trial Of Trastuzumab Deruxtecan (T-Dxd): Her2 And Histopathology Features As Predictors Of Clinical Benefit

S. Modi,B. Glass,A. Prakash,A. Taylor-Weiner,H. Elliott, I. Wapinski,M. Sugihara, K. Saito,J. Kaplan Kerner, R. Phillips, T. Shibutani,K. Honda,A. Khosla,A. H. Beck, J. Cogswell

ANNALS OF ONCOLOGY(2020)

引用 1|浏览17
暂无评分
关键词
advanced breast cancer patients,breast cancer patients,breast cancer,trastuzumab,her2,t-dxd
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要